MitraClip  

The US Food and Drug Administration(FDA) has approved the MitraClip (Abbott Vascular) for patients with symptomatic degenerative mitral regurgitation deemed high risk for mitral-valve surgery [1].

文章標籤

快樂小藥師 發表在 痞客邦 留言(1) 人氣()